Work

Phase II trial of combination biotherapy of high-dose interferon alfa-2b and tremelimumab for recurrent inoperable stage III or stage IV melanoma

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.9009

Authors: A. A. Tarhini, S. S. Moschos, J. J. Schlesselman, J. Shope-Spotloe, M. Demark, J. M. Kirkwood

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2529273456

Cites:

Cited by: 12

Related to: 10